Washington DC… Today, the Trump administration rushed out the partial release of the rules that govern how private health plans must operate in 2022 and in doing so…
Trump Administration temporarily backs off from proposal that would endanger patient copay assistance
Washington DC… In a victory for patients’ ability to afford prescription drugs, the Trump administration has delayed for two years implementation of a provision included in a proposed…
Consumers urged to review health plans to ensure copay assistance for medications counts
Washington DC… As consumers shop for health plans during open enrollment, the HIV+Hepatitis Policy Institute is reminding people, particularly those who depend on prescription drugs, to carefully review plan policies regarding copay assistance…
Trump Administration medicaid proposal endangers patient assistance programs in private insurance market
Washington DC…In a setback to patients’ ability to afford prescription drugs, the Trump administration has again attacked the use of drug manufacturer copay assistance for prescription…
Trump Administration shocks patients by allowing insurers to increase cost of prescription drugs
Washington DC…Today, in a shock to patients, the Trump administration announced that health insurers do not have to count copay assistance from drug manufacturers towards…